ONTOZRY-12.5 mg/25 mg (Cenobamate Tablet) 12.5 mg/25 mg

ONTOZRY-12.5 mg/25 mg is a prescription tablet used alongside other medications to treat seizures in adults with epilepsy. This combination therapy helps manage partial-onset seizures when other treatments are insufficient. ONTOZRY combines two active ingredients for broad anticonvulsant support.

Strength

12.5 mg/25 mg

Pack Size

28s

Storage

Ambient

Manufacturer / TM Owner

ARVELLE THERAPEUTICS

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ONTOZRY-12.5 mg/25 mg is prescribed for adults with epilepsy to control partial-onset seizures. It is typically used when other antiepileptic drugs have not provided adequate seizure control. This medication works as an add-on therapy to reduce seizure frequency and severity. Patients often ask what ONTOZRY is used for in epilepsy management.

Side Effects

ONTOZRY-12.5 mg/25 mg helps stabilize electrical activity in the brain to prevent seizures. Users may experience improved seizure control over time with consistent use. Some individuals report reduced seizure-related anxiety and improved daily functioning. Effects vary by patient and should be monitored by a healthcare provider.

Precautions & Warnings

Store ONTOZRY at room temperature away from moisture and direct light. Keep this medication in its original packaging until ready to use. Always follow your doctor’s instructions for handling and disposal. If you have questions about safe storage, consult your pharmacist or healthcare provider.

Avoid Interactions

ONTOZRY may interact with other medications that affect liver enzymes, including certain antidepressants and antifungals. Alcohol and sedatives can increase drowsiness when combined with this drug. Always inform your doctor about all medications, supplements, and herbal products you are taking. This helps avoid potential interactions.

Frequently Asked Questions

ONTOZRY is used to treat partial-onset seizures in adults with epilepsy, often as an add-on therapy.

Store at room temperature in a dry place away from light and out of reach of children.

Alcohol may increase drowsiness; consult your doctor before consuming alcohol with this medication.

ONTOZRY is not classified as a controlled substance but requires a prescription.

Take the missed dose as soon as you remember, but skip it if it’s almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.